| PCLAX | PCPCX | PCLAX / PCPCX | |
| Total Expense Ratio | 1.22 | 1.97 | 62% |
| Annual Report Gross Expense Ratio | 1.38 | 2.13 | 65% |
| Fund Existence | 16 years | 16 years | - |
| Gain YTD | 6.292 | 5.553 | 113% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.8B | 4.8B | 100% |
| Annual Yield % from dividends | 4.54 | 4.87 | 93% |
| Returns for 1 year | 7.84 | 6.98 | 112% |
| Returns for 3 years | 14.18 | 11.62 | 122% |
| Returns for 5 years | 101.76 | 94.02 | 108% |
| Returns for 10 years | 144.21 | 126.41 | 114% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VCGEX | 7.99 | 0.05 | +0.63% |
| VALIC Company I Emerg Economies | |||
| ERASX | 37.94 | 0.06 | +0.16% |
| Eaton Vance Atlanta Capital SMID-Cap R6 | |||
| IICHX | 12.70 | 0.01 | +0.08% |
| AMF Large Cap Equity H | |||
| JIUCX | 19.26 | 0.01 | +0.05% |
| JPMorgan Developed International Value C | |||
| ITEIX | 10.58 | -0.18 | -1.67% |
| VY® T. Rowe Price Equity Income I | |||